TGFB1 and posterior cortical atrophy: In summary, our results indicate that miR-133b inhibits bone metastasis of PCa by targeting TGFBRI and TGFBRII, leading to inactivation of TGF-β signaling pathway, suggesting that administration of miR-133b may serve as a therapeutic strategy in the treatment of PCa bone metastasis.